Outsourcing veterinary support in preclinical in vivo research is no longer just about filling a capability gap—it’s about selecting a partner that can actively strengthen study quality, regulatory compliance, and overall program success. In the UK in particular, where animal research is governed by some of the world’s most stringent regulations under the Animals (Scientific Procedures) Act 1986 (ASPA), the choice of veterinary provider carries even greater weight.
Here are five critical factors to evaluate when selecting the right outsourced veterinary partner.
Preclinical programs often span multiple sites, timelines, and study phases. A veterinary provider with strong, reliable UK-wide coverage ensures continuity of care and compliance—regardless of where your work is being conducted.
This is particularly important given that all regulated animal research in the UK must take place in licensed establishments and under strict oversight.
A provider with broad geographic reach can:
Without this coverage, sponsors risk delays, inconsistencies in animal care, and compliance gaps that can impact both timelines and data integrity.
Not all veterinarians are equipped for the complexities of preclinical research. In the UK, licensed establishments are required to have access to a named veterinary surgeon with expertise in laboratory animal medicine.
Choosing a provider with dedicated lab animal science vets—rather than general practice vets—is essential.
Specialist lab animal vets bring:
Their role goes beyond clinical care; they actively safeguard animal welfare while enabling scientifically robust outcomes. This dual focus is critical for both regulatory compliance and study validity.
A high-quality veterinary provider should contribute upstream—not just during study execution.
Preclinical in vivo studies are complex, and poor design can lead to unusable data, delays, or regulatory challenges. Veterinary input at the design stage helps ensure:
In addition, training support is a major differentiator. Under UK regulations, personnel involved in animal work must meet defined training and competency requirements.
Providers that offer training can:
This combination of design insight and hands-on training turns a vendor into a true scientific partner.
Navigating the UK regulatory landscape is one of the most complex aspects of preclinical research. Every programme of work involving animals must be authorised under a Project Licence (PPL), which details the scientific rationale, procedures, and animal use.
The application process involves rigorous ethical review, harm–benefit analysis, and ongoing compliance requirements.
A veterinary provider with strong PPL experience can:
This expertise can significantly reduce approval timelines and prevent costly rework or delays.
Finally, one of the most important—and often overlooked—considerations is how flexible the provider is in their service offering.
Preclinical research rarely fits into standardised packages. Study needs evolve, timelines shift, and unexpected challenges arise. Providers offering bespoke veterinary support—rather than rigid, predefined service bundles—are far better equipped to handle this reality.
Bespoke models allow for:
In contrast, fixed service models can create inefficiencies, forcing teams to adapt to the provider rather than the other way around.
Selecting the right outsourced veterinary provider is a strategic decision that directly impacts study quality, regulatory success, and development timelines.
In the UK’s highly regulated environment, the ideal partner combines:
Organisations that prioritise these factors will not only ensure compliance but also enhance the efficiency, reliability, and overall success of their preclinical R&D programs.
Contact us if you’d like to find out more.